{
    "Orphapacket": {
        "ORPHApacketId": "86879",
        "creationDate": "2024-07-01 09:48:26",
        "version": "1.3.29 / 4.1.7 [2023-08-02] (orientdb version)",
        "copyright": "Orphanet (c) 2024",
        "ORPHAcode": "86879",
        "Label": "Extranodal nasal NK/T cell lymphoma",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_86879",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "Angiocentric T-cell lymphoma"
            },
            {
                "Synonym": "Lethal midline granuloma"
            },
            {
                "Synonym": "NK/T-cell lymphoma"
            },
            {
                "Synonym": "NKTCL"
            },
            {
                "Synonym": "Nasal T/natural killer-cell lymphoma"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Extranodal nasal NK/T cell lymphoma (NKTCL) is a rare malignant neoplasm mainly affecting men in the fifth decade of life that usually arises in the nose paranasal sinuses orbits or upper airway and that can present with a nasal mass nasal bleeding nasal obstruction palate perforation (i.e. midline perforation of the hard palate) and mid-facial and/or upper airway destructive lesions. In advanced disease stages which are associated with a poor prognosis NKTCL may disseminate to other organs. A few cases of NKTCL presenting primarily in the lymph nodes have also been described."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "178551",
                        "Label": "Aggressive primary cutaneous T-cell lymphoma"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "289644",
                        "Label": "Epstein-Barr virus-associated malignant lymphoproliferative disorder"
                    }
                ]
            }
        ],
        "Prevalences": {
            "Prevalence": [
                {
                    "Source": "Institut National du Cancer 2013[INST]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "2.25",
                    "PrevalenceGeographic": "France"
                }
            ]
        },
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Adult"
                }
            ]
        },
        "TypeOfInheritances": [
            {
                "TypeOfInheritance": {
                    "value": "Multigenic/multifactorial"
                }
            },
            {
                "TypeOfInheritance": {
                    "value": "Not applicable"
                }
            }
        ]
    }
}